126 related articles for article (PubMed ID: 6274709)
1. [Serum and urine calcitonin levels in patients with medullary thyroid carcinoma and with non-thyroidal cancer, and their immunological size-heterogeneity (author's transl)].
Morimoto S; Onishi T; Imanaka S; Kumahara Y; Okada Y; Takai S; Miyauchi A; Nishioka Y
Nihon Naibunpi Gakkai Zasshi; 1981 Aug; 57(8):1127-38. PubMed ID: 6274709
[No Abstract] [Full Text] [Related]
2. Increased plasma and tumor somatostatin-like immunoreactivity in medullary thyroid carcinoma and small cell lung cancer.
Roos BA; Lindall AW; Ells J; Elde R; Lambert PW; Birnbaum RS
J Clin Endocrinol Metab; 1981 Feb; 52(2):187-94. PubMed ID: 6109732
[No Abstract] [Full Text] [Related]
3. [A comparison of calcitonin production by cultured cells of thyroid glands from patients with medullary or papillary carcinoma in vitro (author's transl)].
Sugenoya A; Miyakawa M; Makiuchi M
Nihon Naibunpi Gakkai Zasshi; 1981 May; 57(5):772-8. PubMed ID: 7286343
[No Abstract] [Full Text] [Related]
4. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
Goltzman D; Tischler AS
J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
[TBL] [Abstract][Full Text] [Related]
5. Release of calcitonin by cultures of medullary carcinoma of the thyroid.
Lichtenberger LM; Singer FR
Endocr Res Commun; 1975; 2(8):527-36. PubMed ID: 1222721
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
Woloszczuk W; Kovarik J
Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
Becker KL; Snider RH; Silva OL; Moore CF
Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
[TBL] [Abstract][Full Text] [Related]
8. The ectopic secretion of calcitonin by lung and breast carcinomas.
Coombes RC; Ellison ML; Easty GC; Hillyard CJ; James R; Galante L; Girgis S; Heywood L; MacIntyre I; Neville AM
Clin Endocrinol (Oxf); 1976; 5 Suppl():387S-396S. PubMed ID: 1053252
[TBL] [Abstract][Full Text] [Related]
9. No effect of cimetidine on calcitonin secretion from medullary thyroid carcinoma.
Emmertsen K; Nielsen HE; Mosekilde L; Hansen HH
Acta Med Scand; 1980; 207(5):367-9. PubMed ID: 7386230
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide and calcitonin in medullary thyroid carcinoma.
Schifter S; Williams ED; Craig RK; Hansen HH
Clin Endocrinol (Oxf); 1986 Dec; 25(6):703-10. PubMed ID: 3308183
[TBL] [Abstract][Full Text] [Related]
11. Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma.
Deftos LJ; Goodman AD; Engelman K; Potts JT
Metabolism; 1971 Apr; 20(4):428-31. PubMed ID: 4994451
[No Abstract] [Full Text] [Related]
12. Immunoassay of calcitonin in rat medullary thyroid carcinoma.
Deftos LJ; Boorman GA; Roos BA
Horm Metab Res; 1976 Jan; 8(1):83-4. PubMed ID: 1248795
[No Abstract] [Full Text] [Related]
13. ACTH and calcitonin secreting medullary carcinoma of the thyroid.
Croughs RJ; Eastham WN; Hackeng WH; Schopman W; Feltkamp-Vroom TM; Dolman A; Hennemann G
Clin Endocrinol (Oxf); 1972 Apr; 1(2):157-71. PubMed ID: 4352168
[No Abstract] [Full Text] [Related]
14. [Serum human calcitonin level in patients with non-thyroidal cancer (author's transl)].
Morimoto S; Onishi T; Nishioka Y; Okada Y; Takai S
Horumon To Rinsho; 1982 Jan; 30(1):75-9. PubMed ID: 6280911
[No Abstract] [Full Text] [Related]
15. Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat.
Roos BA; Deftos LJ; Roberts G; Wilson P; Bundy L
J Lab Clin Med; 1976 Aug; 88(2):173-82. PubMed ID: 822106
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin free oat-cell carcinoma of the thyroid gland.
Eusebi V; Damiani S; Riva C; Lloyd RV; Capella C
Virchows Arch A Pathol Anat Histopathol; 1990; 417(3):267-71. PubMed ID: 2166978
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin.
Roos BA; Huber MB; Birnbaum RS; Aron DC; Lindall AW; Lips K; Baylin SB
J Clin Endocrinol Metab; 1983 Apr; 56(4):802-7. PubMed ID: 6687599
[No Abstract] [Full Text] [Related]
18. Somatostatin inhibits the pentagastrin-induced release of serum calcitonin in medullary carcinoma of the thyroid.
Gordin A; Lamberg BA; Pelkonen R; Almqvist S
Clin Endocrinol (Oxf); 1978 Apr; 8(4):289-93. PubMed ID: 647984
[TBL] [Abstract][Full Text] [Related]
19. Bone remodeling during calcitonin excess: reconstruction of the remodeling sequence in medullary thyroid carcinoma.
Eriksen EF; Kudsk H; Emmertsen K; Mosekilde L; Melsen F
Bone; 1993; 14(3):399-401. PubMed ID: 8363884
[No Abstract] [Full Text] [Related]
20. [Medullary carcinoma of the thyroid gland producing calcitonin].
Ston J; Broulík P; Pacovský V; Cieslar P; Dorazilová V
Sb Lek; 1972 Mar; 74(3):81-5. PubMed ID: 5011638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
